Difference between revisions of "Team:BostonU/App 2/Results"
Line 23: | Line 23: | ||
<p>This important result gave us some experimental validation that our model could offer scientists insights into choosing promising viable split sites for proteins, without only relying on 3D structures of proteins.</p> | <p>This important result gave us some experimental validation that our model could offer scientists insights into choosing promising viable split sites for proteins, without only relying on 3D structures of proteins.</p> | ||
+ | |||
+ | <h4>Citations</h4> | ||
+ | <ol font-size=10px;> | ||
+ | <li>Sander, Jeffry D., Joung, J. Keith, “CRISPR-Cas systems for editing, regulating, and targeting genomes”, Nature Biotechnology, 2013.</li> | ||
+ | <li>Zetsche, Bernd, Volz, Sara E., Zhang, Feng, “A split-Cas9 architecture for inducible genome editing and transcription modulation”, Nature Biotechnology, 2015.</li> | ||
+ | <li>Daya, Shyam, Berns, Kenneth I., “Gene Therapy using Adeno-Associated Virus Vectors”, Clinical Microbiology Reviews, 2008.</li> | ||
+ | <li>Zhang, Feng et al., “In vivo genome editing using Staphylococcus aureus Cas9”, Nature, 2015.</li> | ||
+ | <li>Scharenberg, Andrew M. et al., “Tracking genome engineering outcome at individual DNA breakpoints”, Nature Methods, 2011.</li> | ||
+ | <li>Cox, David Benjamin Turitz, Platt, Randall Jeffrey, Zhang, Feng, “Therapeutic Genome Engineering: prospects and challenges”, Nature Medicine, 2015.</li> | ||
+ | <li>Nureki, Osamu et al., “Crystal structure of staphylococcus aureus Cas9”, Cell, 2015.</li> | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 15:46, 17 September 2015
Motivation | Design | Results |